Gain Therapeutics Showcases Allosteric Small Molecule Therapies at J.P. Morgan Healthcare Conference Week

Reuters
Jan 07
Gain <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Showcases Allosteric Small Molecule Therapies at J.P. Morgan Healthcare Conference Week

Gain Therapeutics Inc. will participate in several events during the week of the 44th Annual J.P. Morgan Healthcare Conference. The company will present at the 9th Annual Sachs Neuroscience Innovation Forum on January 11, 2026, at the Marine's Memorial Club in San Francisco. Gain will also attend the Demy-Colton/Informa Biotech Showcase from January 12-14, 2026, at the Hilton San Francisco Union Square, and the LifeSci Advisors 15th Annual Corporate Access Event on January 14, 2026, at The Beacon Grand in San Francisco. These events will feature presentations and one-on-one meetings with Gain management.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gain Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9621284-en) on January 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10